J. Scott Roberts, PhD, from the Department of Health Behavior and Health Education, University of Michigan School of Public Health, discusses study results.
Read More
A new AAN guideline "Assessment: The role of diffusion and perfusion MRI for the diagnosis of acute ischemic stroke" was published.
Read More
Eric Logigian, MD, and Richard T. Moxley, III, MD, from the University of Rochester School of Medicine and Dentistry, discuss their paper "Mexiletine is an effective antimyotonia treatment in myotonic dystrophy type 1" that was recently published.
Read More
Ted M. Burns, MD, Associate Professor of Neurology at the University of Virginia, discusses his paper "The MG composite: a valid and reliable outcome measure for myasthenia gravis" that was recently published.
Read More
Åsa Wallin, MD, PhD, and Oskar Hansson MD, PhD, both at the Department of Clinical Sciences of Lund University in Malmö, Sweden, discuss their paper "CSF biomarkers predict a more malignant outcome in Alzheimer's disease."
Read More
David Dingli, MD, PhD, Associate Professor in the Department of Hematology at the Mayo School of Medicine, discusses his paper, "Stem cell transplantation in patients with autonomic neuropathy due to primary (AL) amyloidosis," which was recently published.
Read More
Amalia Bruni, MD, from the Centro Regionale di Neurogenetica, Azienda Sanitaria Provinciale Catanzaro, discusses her paper, "Worldwide distribution of PSEN1 Met146Leu mutation: A large variability for a founder mutation."
Read More
Ruth Ann Marrie, MD, PhD, Director of the Multiple Sclerosis Clinic, and Assistant Professor of Medicine and Community Health Sciences at the University of Manitoba, talks about vascular comorbidities and risk factors and their effect on the progression of multiple sclerosis. Her paper, "Vascular comorbidity is associated with more rapid disability progression in multiple sclerosis," was published recently in Neurology®.
Read More
Kenneth M. Heilman, MD, describes his first encounter with what he calls "academic addiction." Also known as research addiction, the curiosity inspired by his interactions with a young patient with unusual symptoms has led him to a lifelong quest for the research high that comes from solving seemingly insoluble puzzles. His analysis of the "research high" experience—"like substance abuse addicts, our mesolimbic dopamine system was probably activating our nucleus accumbens"—provides a suitable neurologic backdrop for this insightful essay on the human brain in the throes of scientific research.
Read More
Theresa Zesiewicz, MD, FAAN, professor of neurology in the Department of Neurology at the University of South Florida, Tampa, Florida, discusses the new AAN guideline, "Treatment of Nonmotor Symptoms of Parkinson Disease," and the need for further studies in the field.
Read More
Science Editor José G. Merino, MD, MPhil, provides an overview of developments in his web section. The new design of AAN.com allows members to get involved with the Academy in ways never before possible, and his editorial board will play an active role in developing exciting new features on the website.
Read More
Archives |
